Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06881173

The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis

Efficacy of Meridian Energy and Heart Rate Variability in Patients with Ocular Myasthenia Gravis by Using Chinese and Western Medicine Treatment

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
112 (estimated)
Sponsor
Cheng, yu-ting · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Research Background: According to the Myasthenia Gravis Foundation of America (MGFA, 2015), the estimated prevalence of myasthenia gravis is 14-20 per 100,000 people, with a higher prevalence in young female individuals compared to males. However, as individuals age, especially after the age of 50, the prevalence in males becomes higher than in females. myasthenia gravis patients often experience varying degrees of disability, leading to the need for long-term medical care, medication, and lifestyle adjustments. This also gives rise to subsequent challenges in caregiving, affecting both the patients' families and society.

Detailed description

:This study aims to assess the effectiveness of using a combination of traditional Chinese and Western medicine,to improve the meridian energy and autonomic nervous system function of myasthenia gravis patients.

Conditions

Interventions

TypeNameDescription
DRUGBu Zhong Yi Qi TangThe experimental group took 15g of Buzhong Yiqi Decoction concentrated powder, 3 times a day, 1 packet each time.
DRUGcaramel dyed starch placeboThe control group took 15 grams of caramel dyed starch placebo, 1 pack at a time, 3 times a day.

Timeline

Start date
2022-06-14
Primary completion
2025-06-13
Completion
2025-06-13
First posted
2025-03-18
Last updated
2025-03-20

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06881173. Inclusion in this directory is not an endorsement.